JPMorgan Chase & Co’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.69K Sell
2025
Q1
$17.2K Sell
2024
Q4
$155K Sell
2024
Q3
$238K Buy
2024
Q2
$30.4K Buy
2024
Q1
$35.5K Sell
2023
Q4
$164K Buy
2023
Q3
$254K Buy
2023
Q2
$89.8K Buy
2023
Q1
$84K Buy